---
title: "Regeneron Says FDA Approves Pasatru (Garetosmab-Grts) For Adults With Fibrodysplasia Ossificans Progressiva"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296391680.md"
datetime: "2026-08-19T19:19:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296391680.md)
  - [en](https://longbridge.com/en/news/296391680.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296391680.md)
generator: "portal-rs"
---

# Regeneron Says FDA Approves Pasatru (Garetosmab-Grts) For Adults With Fibrodysplasia Ossificans Progressiva

Aug 20 (Reuters) - Regeneron Pharmaceuticals, Inc. (REGN.O) : \* REGENERON PHARMACEUTICALS, - FDA APPROVES PASATRU (GARETOSMAB-GRTS) FOR ADULTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA \* REGENERON PHARMACEUTICALS, - PASATRU UNDER REVIEW BY EUROPEAN MEDICINES AGENCY; GLOBAL SUBMISSIONS PLANNED Source text: Further company coverage: (REGN.O)

### Related Stocks

- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)

## Related News & Research

- [Regeneron says FDA approves Pasatru for adults with rare bone disorder FOP](https://longbridge.com/en/news/296387064.md)
- [Regeneron podcast turns science into immersive experience](https://longbridge.com/en/news/296758441.md)
- [Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drug](https://longbridge.com/en/news/296499413.md)
- [Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims](https://longbridge.com/en/news/296616209.md)
- [04:39 ETRegeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN](https://longbridge.com/en/news/296589805.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**